This audio is auto-generated. Please let us know if you have feedback.
Dive Brief:
- Walgreens has inked a clinical trial deal with major German drugmaker Boehringer Ingelheim.
- Under the deal, Walgreens will find candidates who are overweight or have obesity or diabetes and connect them with a Phase III clinical trial for Boehringer’s GLP-1 drug survodutide, according to a release.
- Walgreens…